ARTICLE | Company News
Intronn LLC other research news
July 2, 2001 7:00 AM UTC
Intronn received a $2.5 million two-year Phase II SBIR grant from the National Institute of Diabetes, Digestive and Kidney Diseases to develop its SMaRT technology to repair the genetic defect in cyst...